ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,307Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 387

$1.01M Total Retail Price of All Prescriptions

Rank: 29 out of 387

754 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 754 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 754 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 14,036 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
SIMVASTATIN 745 682 1 5
LEVOTHYROXINE SODIUM 630 600 2 2
OMEPRAZOLE 518 473 3 4
HYDROCODONE-ACETAMINOPHEN 469 457 S3 4 1
LISINOPRIL 425 352 5 3
AMLODIPINE BESYLATE 360 360 6 6
FUROSEMIDE 319 309 7 7
GABAPENTIN 290 265 8 10
POTASSIUM CHLORIDE 285 275 9 9
HYDROCHLOROTHIAZIDE 271 240 10 12
METFORMIN HCL ER 264 231 11 81
CITALOPRAM HBR 241 217 12 19
TRAMADOL HCL 224 200 13 14
PRAVASTATIN SODIUM 223 223 14 15
METFORMIN HCL 206 182 15 8
AZITHROMYCIN 181 174 16 49
METOPROLOL TARTRATE 177 174 17 11
ATORVASTATIN CALCIUM 176 159 18 13
CARVEDILOL 171 151 19 21
METOPROLOL SUCCINATE 159 158 20 18
ALLOPURINOL 158 153 21 28
TAMSULOSIN HCL 152 139 22 32
CLOPIDOGREL 147 145 23 25
NAMENDA 144 131 24 35
LISINOPRIL-HYDROCHLOROTHIAZIDE 144 143 24 30
ZOLPIDEM TARTRATE 141 138 26 16
DOXAZOSIN MESYLATE 140 128 27 75
DONEPEZIL HCL 139 139 28 27
CYMBALTA 130 126 29 44
CRESTOR 129 126 30 34
EVISTA 124 117 31 111
CIPROFLOXACIN HCL 124 117 31 56
LOSARTAN POTASSIUM 123 111 33 24
GLIMEPIRIDE 122 118 34 50
ATENOLOL 119 119 35 20
RISPERIDONE 116 112 36 70
ALENDRONATE SODIUM 112 99 37 31
NEXIUM 111 106 38 26
DIOVAN 111 111 38 33
FLUTICASONE PROPIONATE 104 86 40 29
LANTUS 102 80 41 51
ENALAPRIL MALEATE 102 94 41 69
PLAVIX 101 98 43 39
OXYBUTYNIN CHLORIDE 95 92 44 134
MIRTAZAPINE 93 69 45 64
MELOXICAM 91 77 46 22
WARFARIN SODIUM 89 89 47 17
PANTOPRAZOLE SODIUM 86 86 48 48
FENOFIBRATE 84 84 49 106
FINASTERIDE 83 71 50 95
ESCITALOPRAM OXALATE 80 71 51 73
NOVOLOG 79 68 52 116
BENAZEPRIL HCL 77 73 53 86
TRIAMTERENE-HCTZ 76 57 54 55
LYRICA 76 76 54 66
BISOPROLOL-HYDROCHLOROTHIAZIDE 76 46 54 144
FENTANYL 75 62 S2 57 80
SPIRONOLACTONE 73 58 58 67
METHYLPREDNISOLONE 70 69 59 101
RANITIDINE HCL 70 62 59 45
TRAZODONE HCL 63 38 61 37
DIOVAN HCT 63 62 61 74
ROPINIROLE HCL 62 62 63 91
LANTUS SOLOSTAR 62 57 63 102
AMITRIPTYLINE HCL 62 59 R 63 62
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 46 66 90
SERTRALINE HCL 59 57 67 23
VENLAFAXINE HCL ER 58 48 68 97
SINGULAIR 57 34 69 83
POLYETHYLENE GLYCOL 3350 56 46 70 57
CLONIDINE HCL 55 49 71 38
PAROXETINE HCL 55 54 71 52
PROPRANOLOL HCL 55 55 71 100
SYNTHROID 52 51 74 68
ZETIA 51 51 75 96
HUMALOG 51 42 75 223
LOSARTAN-HYDROCHLOROTHIAZIDE 51 48 75 65
BACLOFEN 50 27 78 154
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 1, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.